GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Share-based Compensation (2016 - 2026)

GridAI Technologies' (GRDX) quarterly Share-based Compensation came in at $582500.0 in Q2 2026, up 21012.72% on a YoY basis from N/an in Q2 2025, and down 20.63% quarter-over-quarter from $733950.0 in Q4 2025.

Analysis

GridAI Technologies (GRDX) Share-based Compensation (2016 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Share-based Compensation for 11 consecutive years, with $582500.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation rose 21012.72% year-over-year to $582500.0; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (up 75922.11% YoY), and the FY2025 full-year result was $1.2 million, down 24.77% from the prior year.
  • Share-based Compensation fell to $582500.0 in Q2 2026 per GRDX's latest filing, from $733950.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.9 million in Q1 2022 and bottomed at $2759.0 in Q2 2025.
  • Historically, Share-based Compensation has averaged $673547.1 across 5 years, with a median of $757475.0 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Share-based Compensation sank 98.63% in 2025, then surged 21012.72% in 2026.
  • Over 5 years, Share-based Compensation stood at $84346.0 in 2022, then soared by 49.53% to $126122.0 in 2023, then sank by 38.16% to $78000.0 in 2024, then soared by 840.96% to $733950.0 in 2025, then retreated by 20.63% to $582500.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $582500.0, $733950.0, and $817644.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 83.34 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 582,500.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 582,500.00
Dec 31, 2025 733,950.00
Sep 30, 2025 817,644.00
Jun 30, 2025 2,759.00
Mar 31, 2025 969,356.00
Sep 30, 2024 78,000.00
Jun 30, 2024 201,077.00
Mar 31, 2024 781,000.00
Dec 31, 2023 126,122.00
Sep 30, 2023 600,000.00
Jun 30, 2023 800,000.00
Mar 31, 2023 1.10 Mn
Dec 31, 2022 84,346.00
Sep 30, 2022 900,000.00
Jun 30, 2022 1.10 Mn
Mar 31, 2022 1.90 Mn
Sep 30, 2021 1.10 Mn
Jun 30, 2021 4.30 Mn
Mar 31, 2021 2.47 Mn
Dec 31, 2020 152,616.00